+91-8668442535

Hemostasis And Tissue Sealing Agents Market By Product (Hemostats, Sealants, Adhesives) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Industry Outlook

Hemostasis and tissue sealing agents are material used for restricting bleeding or hemorrhage caused from injuries or during surgical procedures. Perpetual innovation in the field of hemostasis, and increased volume of surgical procedures together drive the growth of this market. Growth in the prevalence of chronic diseases and geriatric population has led to increased number of surgeries performed worldwide. Conditions such as cardiovascular diseases, hernia, ophthalmic conditions, gynecological and urological conditions, and burns frequently require surgical intervention wherein hemostats and tissue sealants are required.

Hemostats and tissue sealing agents are used for prevention of blood loss and have wide application in surgical procedures. Minimally invasive surgical interventions are particular areas where hemostats are frequently used. Therefore, growing trend of adoption of minimally invasive surgeries promote the growth of hemostasis and tissue sealing agents market. However, lack of widespread and appropriate reimbursement to these products restrains the desired market growth.

Market Synopsis

Hemostasis And Tissue Sealing Agents Market

Get a sample copy for more information

Increasing Count of Surgical Procedures to Intensify the Market Growth

Based on the product types, the global hemostasis and tissue sealing agents market is categorized into hemostats, sealants and adhesives. The hemostats segment is further categorized as mechanical, active and flowable hemostats; sealants as fibrin and synthetic sealants; adhesives as Cyanoacrylate and, albumin and glutaraldehyde. Among these, hemostats segment enjoys the largest revenue share in the global market as these products offer greater cost efficiency, quick sealing properties and low tissue reactivity. Sealants and adhesives will witness rapid market growth during the forecast period on the ground of their proven efficiency in preventing blood loss from surgical sites in combination with other drugs. Growing demand of these products over surgical sutures is due to their faster application rate, less invasion, lower risk of infections and lesser exudate discharge. The market players engaged in production of hemostats and tissue sealing agents are engaged in production of novel agents that have wider applicability than the existing ones.  Furthermore, efforts are also being undertaken to bring innovation towards introducing natural sealants, which will have better bioavailability and therefore witness fast market growth.

Hemostasis And Tissue Sealing Agents Market

Get a sample copy for more information

North America and Asia Pacific to Remain the Most Prominent Regional Markets

At present, North America has largest revenue contribution in the global hemostasis and tissue sealing agents market. High prevalence of chronic diseases such as diabetes, and cancer in the region promote the dominance of North America market. Europe is estimated as the second largest regional market as the region witnesses swift approval to novel and technologically advanced products in the healthcare system, along with greater incidence of surgical procedures. Aggressive marketing of novel surgical products to surgeons also facilitates the dominance of Europe and North America on the global front. Additionally, Asia Pacific is anticipated to undergo the fastest market growth during the forecast period from 2018 to 2026. Favorable government policies and increasing healthcare expenditure, along with large potential patient pool contribute to the swift pace of Asia Pacific market. The burgeoning medical tourism industry in the region also supports the market growth in Asia Pacific.

Hemostasis And Tissue Sealing Agents Market

Get a sample copy for more information

Hemostasis And Tissue Sealing Agents Market

Historical & Forecast Period

This research report presents the analysis of each considered segment for the period from 2016 to 2026, having 2017 as the base year for estimations. Compounded annual growth rates (CAGRs) for each segment are calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

This report on global hemostasis and tissue sealing agents market offers both qualitative and quantitative analysis of the industry in terms of market size and forecast and the prevalent market dynamics. For the purpose of this study, the global hemostasis and tissue sealing agents market is studies for product types and geography.

ATTRIBUTE DETAILS
Research Period  2016-2026
Base Year 2017
Forecast Period  2018-2026
Historical Year  2016
Unit  USD Million
Segmentation

 By Products (2016–2026; US$ Mn)
 • Hemostats
 • Mechanical
 • Active
 • Flowable
 • Sealants
 • Fibrin Sealants
 • Synthetic Sealants, PEG-based
 • Adhesives
 • Cyanoacrylate
 • Albumin and Glutaraldehyde

 Geography Segment (2016–2026; US$ Mn)
 • North America (United States and Canada)
 • Europe (U.K., Germany, Rest of Europe)
 • Asia Pacific (China, Japan, Rest of Asia Pacific)
 • Latin America (Brazil, Mexico, Rest of Latin America)
 • Middle East and Africa (GCC, Rest of MEA)

The market dynamics in the hemostasis and tissue sealing agents industry are assessed for vivid understanding of the industry development. The dynamics for the global hemostasis and tissue sealing agents market are categorized into drivers, challenges, and opportunities. The report also includes competitive analysis of the prominent players in the global hemostasis and tissue sealing agents. The profiles of such players are also assessed in the study based on their business overview, product portfolio, financial information, and key developments. The prime players operating in the global hemostasis and tissue sealing agents market are Baxter International, Inc., Johnson & Johnson, CryoLife, Inc., Advanced Medical Solutions Group plc, Cohera Medical, Inc., Integra LifeSciences Corporation, Pfizer, Inc., C R Bard Inc., Cohesion Technologies, Inc., Zimmer Biomet, and B Braun Medical Inc.

Key questions answered in this report

  • What is the current status of the global hemostasis and tissue sealing agents market, and how the global market will progress through the forecast period?
  • What are the major market drivers, and challenges prevalent in the global hemostasis and tissue sealing agents market?
  • Which are the key market opportunities available for the market players to harness?
  • Where the tissue sealing agents market seen by 2026?
  • How are the major market players shaping their strategies for retaining or augmenting their competitive edge?
  • Which regional market will undergo the fastest market growth during the forecast period?
  • Will the positions of North America and Europe markets be challenged by the rapid advances of Asia Pacific market?
  • What is the current status of the competitive landscape of the global hemostasis and tissue sealing agents market?
Choose License Type
Budget Buying
Executive Summary - Brief Global Market Size - Current & Forecast
Regional Market Size - North America
Country Market Size - US
Company Profile – 1
Trusted By
Godaddy
Related Report










Published Date:  Aug 2018
Category:  Medical Devices
Report ID:   59282
Report Format:   PDF
Pages:   120
Rating:    4.4 (40)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support